scholarly journals Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study

Haematologica ◽  
2018 ◽  
Vol 103 (8) ◽  
pp. 1298-1307 ◽  
Author(s):  
Carlo Gambacorti-Passerini ◽  
Jorge E. Cortes ◽  
Jeff H. Lipton ◽  
Hagop M. Kantarjian ◽  
Dong-Wook Kim ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Phase I ◽  
Myeloid Leukemia ◽  
Chronic Phase ◽  
Second Line ◽  
Safety And Efficacy

Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase

2018 ◽  
Vol 168 (7) ◽  
pp. 461 ◽  
Author(s):  
François-Xavier Mahon ◽  
Carla Boquimpani ◽  
Dong-Wook Kim ◽  
Noam Benyamini ◽  
Nelma Cristina D. Clementino ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Chronic Phase ◽  
Second Line ◽  
Treatment Free Remission

Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy

2018 ◽  
Vol 74 ◽  
pp. 75-79 ◽  
Author(s):  
Massimiliano Bonifacio ◽  
Luigi Scaffidi ◽  
Gianni Binotto ◽  
Maria Cristina Miggiano ◽  
Marco Danini ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Chronic Phase ◽  
Safety And Efficacy

ENESTop 192-Weeks Results: Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After Stopping Second-Line Nilotinib

2019 ◽  
Vol 19 ◽  
pp. S288-S289 ◽  
Author(s):  
Francois-Xavier Mahon ◽  
Carla Boquimpani ◽  
Naoto Takahashi ◽  
Noam Benyamini ◽  
Nelma Cristina D. Clementino ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Chronic Phase ◽  
Second Line ◽  
Treatment Free Remission

Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with second-line nilotinib (NIL): First results from the ENESTop study.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 7054-7054 ◽  
Author(s):  
Timothy P Hughes ◽  
Carla Boquimpani ◽  
Dong-Wook Kim ◽  
Noam Benyamini ◽  
Nelma Cristina D. Clementino ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Chronic Phase ◽  
Second Line ◽  
First Results ◽  
Treatment Free Remission

Long-term treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) after stopping second-line (2L) nilotinib: ENESTop 144-wk results.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 7003-7003 ◽  
Author(s):  
François-Xavier Mahon ◽  
Carla Boquimpani ◽  
Naoto Takahashi ◽  
Noam Benyamini ◽  
Nelma Cristina D. Clementino ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Chronic Phase ◽  
Term Treatment ◽  
Second Line ◽  
Long Term Treatment ◽  
Treatment Free Remission
Sign in / Sign up

Export Citation Format

Share Document